Cancer Genetics Secures $5,500,000 New Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=aa45273c-9efb-41e6-92e5-86be982dbeb0 - Date
12/7/2016 - Company Name
Cancer Genetics - Mailing Address
133 Southcenter Court Rutherford, NC 27560 USA - Company Description
Cancer Genetics, Inc. develops, commercializes, and provides molecular and biomarker-based tests and services in the United States, India, and China. - Website
http://www.cancergenetics.com - Transaction Type
Venture Equity - Transaction Amount
$5,500,000 - Transaction Round
Undisclosed - Proceeds Purposes
Proceeds purposes were not disclosed. 16 investors participated in the offering. The amount may include options, warrants or other securities. Contact technology company for investment details, if applicable. Not an offer or solicitation for the sale of securities or debt. SEC regulatory filing. - M&A Terms
- Venture Investor
Undisclosed
